Neurodegeneration is a neurological disorder with the tendency to develop atrophy and irreversible damage of neurons. Alzheimer''s (AD) and Parkinson''s (PD) are two of the most common neurodegenerative diseases. GDNF, NGF, and BDNF are development factors that can be used in clinical trials to support neurodegenerative diseases. Clinical trials of GDNF (therapy for PD), NGF, and BDNF (therapeutic option for AD and PD) are in progress.
Neurodegenerative Diseases are therapeutic targets
